Recent advancement in flavivirus vaccine development

GJJ Chang, G Kuno, DE Purdy… - Expert Review of …, 2004 - Taylor & Francis
Lately, the magnitude of cumulative diseases burden caused by flaviviruses, such as
dengue virus, Japanese encephalitis virus, tick-borne encephalitis virus, West Nile virus and …

Chromatographic and related electrophoretic methods in the separation of transition metal complexes or their ligands

RE Shepherd - Coordination chemistry reviews, 2003 - Elsevier
It is difficult for most inorganic chemists to be aware of the availability of the many new
techniques, described largely in analytical chemistry, environmental chemistry, and …

[PDF][PDF] An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes

B Etemad, G Batra, R Raut, S Dahiya, S Khanam… - Am J Trop Med …, 2008 - Citeseer
There is currently no vaccine to prevent dengue (DEN) virus infection, which is caused by
any one of four closely related serotypes, DEN-1, DEN-2, DEN-3, or DEN-4. A DEN vaccine …

High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli

S Jaiswal, N Khanna, S Swaminathan - Protein expression and purification, 2004 - Elsevier
Dengue virus infection poses a serious global public health threat for which there is currently
no therapy or a licensed vaccine. The domain III of the dengue virus encoded envelope …

Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies

S Mani, L Tripathi, R Raut, P Tyagi, U Arora, T Barman… - PLoS one, 2013 - journals.plos.org
Dengue is a mosquito-borne viral disease with a global prevalence. It is caused by four
closely-related dengue viruses (DENVs 1–4). A dengue vaccine that can protect against all …

[PDF][PDF] Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope …

MG Guzmán, R Rodriguez, R Rodriguez… - The American journal …, 2003 - academia.edu
A recombinant vaccine that expresses the envelope (E) gene of dengue virus type 4 was
tested for immunogenicity and protection in Macaca fascicularis. One hundred micrograms …

Determination of β‐Agonist Residues in Animal‐Derived Food by a Liquid Chromatography‐Tandem Mass Spectrometric Method Combined with Molecularly …

J Tang, J Wang, S Shi, S Hu… - Journal of Analytical …, 2018 - Wiley Online Library
A novel clenbuterol molecularly imprinted polymer (MIP)‐coated stir bar was prepared and
applied to the determination of six β‐agonists in animal‐derived food. Characterization and …

[HTML][HTML] Treinta años después de la epidemia cubana de dengue hemorrágico en 1981

MG Guzmán Tirado - Revista Cubana de Medicina Tropical, 2012 - scielo.sld.cu
En 1981, Cuba reportó la primera epidemia de dengue hemorrágico en las Américas, en la
cual se reportaron más de 344 203 enfermos, con 10 312 casos graves y muy graves, y 158 …

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen

H Bisht, DA Chugh, M Raje, S Swaminathan… - Journal of …, 2002 - Elsevier
A truncated version of the dengue virus type 2 envelope protein (Den2E) encoding the first
395 amino acid (aa) residues, and Den2E fused in-frame with the full-length 226-aa …

[PDF][PDF] Thirty years after the Cuban hemorrhagic dengue epidemic of 1981

MG Guzmán - MEDICC review, 2012 - SciELO Public Health
In 1981, Cuba reported the first hemorrhagic dengue epidemic in the Americas, with
344,203 cases, including 10,312 severe and very severe cases, resulting in 158 deaths. In …